Back to Article List

FDA Taiwan Publishes Restrictions and Labelling of Genetically Modified E.Coli in Food Ingredient


Dec 29, 2020

The Republic of China issued “Restrictions and labelling of food raw materials produced by fermentation of genetically modified E.Coli (Escherichia Coli) BL21 (DE3) 1540 strains 2'- algal saccharides (2' fucosyllactose)”.

These provisions are made in accordance with the provisions of Article 15 (2) and Article 22 (1) (10) of the Food Safety and Health Administration Law.

  • This provision is set at 2'-algal saccharide-based lactose (2'-fucosyllactose) for genetically modified E.Coli (Escherichia Coli) BL21 (DE3) after fermentation of the strain.
    The resulting sequestration is sterilely filtered to remove fermented strains and their biomass.

  • Process includes purification steps such as cation and anion exchange layering, concentration, activated carbon treatment, electrodialysis and filtration.

  • End results contains no traces of genetically modified microorganisms and their transgene fragments.

For further information (in English), click on the Link

"Story Supplied courtesy of Selerant".

Related Articles
See All News
Subscribe to our newsletter

The best industry insight in your mailbox